Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Tumor of Urinary Bladder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT03839472
What this trial is testing

Continuous Bladder Irrigation Following Transurethral Resection of Bladder Tumors

Who this might be right for
Non-muscle Invasive Bladder Cancer (NMIBC)Bladder Tumor (TURBT)
Case Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00003657
What this trial is testing

High-dose ICE With Amifostine

Who this might be right for
Bladder CancerBrain and Central Nervous System TumorsCarcinoma of Unknown Primary+8 more
Dana-Farber Cancer Institute 24
Not applicableUnknownNCT05704231
What this trial is testing

The Effect of Telephone-Assisted Smoking Cessation Program in Patients Diagnosed With Non-Muscle Invasive Bladder Cancer

Who this might be right for
Non-Muscle Invasive Bladder CancerSelf EfficacySmoking Behaviors+2 more
Bakirkoy Dr. Sadi Konuk Research and Training Hospital 60
Testing effectiveness (Phase 2)Ended earlyNCT04424641
What this trial is testing

A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumor(s)Prostate CancerEsophageal Cancer+5 more
Genmab 48
Testing effectiveness (Phase 2)Looking for participantsNCT05267626
What this trial is testing

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Who this might be right for
Advanced Solid TumorMetastatic CancerCutaneous Melanoma+1 more
Aulos Bioscience, Inc. 159
Testing effectiveness (Phase 2)Looking for participantsNCT05710848
What this trial is testing

STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer

Who this might be right for
Non-muscle-invasive Bladder Cancer
SURGE Therapeutics 75
Large-scale testing (Phase 3)Study completedNCT04209114
What this trial is testing

Nivolumab Plus Bempegaldesleukin (Bempeg/NKTR-214) vs Nivolumab Alone vs Standard of Care in Participants With Bladder Cancer That May Have Invaded The Muscle Wall of the Bladder and Who Cannot Get Cisplatin, A Type of Medicine Given To Treat Bladder Cancer

Who this might be right for
Bladder CancerBladder TumorMuscle-Invasive Bladder Cancer
Bristol-Myers Squibb 114
Not applicableWithdrawnNCT04985357
What this trial is testing

Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs

Who this might be right for
Stage III Breast CancerStage IV Breast CancerStage III Lung Cancer+35 more
Travera Inc
Not applicableUnknownNCT00757614
What this trial is testing

Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom

Who this might be right for
Bladder CancerBrain and Central Nervous System TumorsEsophageal Cancer+6 more
Cancer Research UK 14,000
Early research (Phase 1)Study completedNCT02262455
What this trial is testing

Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors

Who this might be right for
Ovarian CancerFallopian Tube CancerEndometrial Cancer+1 more
Santa Maria Biotherapeutics 32
Not applicableActive Not RecruitingNCT05520099
What this trial is testing

Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform (ELEPHAS-02)

Who this might be right for
ImmunotherapyCancerBladder Cancer+16 more
Elephas 416
Early research (Phase 1)Study completedNCT02223052
What this trial is testing

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

Who this might be right for
Hematological NeoplasmsNon-Hodgkin's LymphomaHodgkin's Lymphoma+17 more
Celgene 89
Early research (Phase 1)Active Not RecruitingNCT05768347
What this trial is testing

Intravesical Adoptive Cell Therapy w/ TIL for BCG Exposed High Grade NMIBC

Who this might be right for
Urothelial CarcinomaNon-Invasive Bladder Urothelial Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 9
Not applicableEnded earlyNCT00904514
What this trial is testing

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 241
Early research (Phase 1)Study completedNCT00083213
What this trial is testing

Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Cancer
Regeneron Pharmaceuticals 25
Testing effectiveness (Phase 2)Study completedNCT04742959
What this trial is testing

Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorCholangiocarcinomaHER2-negative Breast Cancer+8 more
TransThera Sciences (Nanjing), Inc. 203
Early research (Phase 1)Study completedNCT04200963
What this trial is testing

A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma

Who this might be right for
Urothelial CarcinomaUrothelial Carcinoma BladderBladder Cancer+18 more
Ikena Oncology 78
Early research (Phase 1)Looking for participantsNCT06465069
What this trial is testing

LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Who this might be right for
Metastatic Solid TumorRecurrent Solid TumorAdvanced Solid Tumor+11 more
Eli Lilly and Company 420
Early research (Phase 1)Ended earlyNCT03518320
What this trial is testing

Safety and Tolerability of TAR-200 and Nivolumab in Subjects With Muscle-Invasive Bladder Cancer

Who this might be right for
Bladder Cancer TNM Staging Primary Tumor (T) T2Bladder Cancer TNM Staging Primary Tumor (T) T2ABladder Cancer TNM Staging Primary Tumor (T) T2B+6 more
Taris Biomedical LLC 13
Not applicableLooking for participantsNCT06310759
What this trial is testing

Prospective Validation Study of High Volume Urine DNA Testing in Individuals With Suspicion of Urothelial Cancer

Who this might be right for
Urothelial Carcinoma
Tampere University Hospital 3,000
Next Page